SHLP2 Dosage Guide
Complete guide to SHLP2 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
1 mg – 5 mg
Frequency
Once per day
Route
subcutaneous
Cycle Length
4–8 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Research compound with doses in the microgram to low milligram range studied in animal models.
Human dosing not established.
Administration Method
Subcutaneous or intraperitoneal injection in research settings. Various SHLP analogs (1-6) have different properties.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 1.200 ml
Syringe units: 120.0 units — exceeds 1 ml syringe, split into multiple injections
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with SHLP2 defaults. Adjust values as needed.
Side Effects to Monitor
Limited data. Animal studies suggest good tolerability. May affect glucose metabolism.
Safety Considerations & Risks
Highly experimental. Most data from animal models. Human safety and efficacy not established.